Pandolfini L, Luzi E, Bressan D, Ucciferri N, Bertacchi M, Brandi R, et al. RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells. Genome Biol. 2016;17:94 pubmed 出版商

Yao M, Su P, Li Z, Cui X, Yang Q, Xing X, et al. Knockout of Dip2c in murine ES cell line IBMSe001-B-1 by CRISPR/Cas9 genome editing technology. Stem Cell Res. 2021;53:102236 pubmed 出版商

Li W, Kou J, Qin J, Li L, Zhang Z, Pan Y, et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat Metab. 2021;3:75-89 pubmed 出版商

Baruah J, Chaudhuri S, Mastej V, Axen C, Hitzman R, Ribeiro I, et al. Low-Level Nanog Expression in the Regulation of Quiescent Endothelium. Arterioscler Thromb Vasc Biol. 2020;40:2244-2264 pubmed 出版商

Hayward B, Steinbach P, Usdin K. A point mutation in the nuclease domain of MLH3 eliminates repeat expansions in a mouse stem cell model of the Fragile X-related disorders. Nucleic Acids Res. 2020;: pubmed 出版商

Sun H, Yang X, Liang L, Zhang M, Li Y, Chen J, et al. Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency. EMBO J. 2020;39:e102961 pubmed 出版商

Srivastava Y, Tan D, Malik V, Weng M, Javed A, Cojocaru V, et al. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17. FEBS J. 2020;287:122-144 pubmed 出版商

Liu Z, Yao M, Yao H, Hu G, Qin B. Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology. Stem Cell Res. 2019;41:101638 pubmed 出版商

Malik V, Glaser L, Zimmer D, Velychko S, Weng M, Holzner M, et al. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2. Nat Commun. 2019;10:3477 pubmed 出版商

Castelli A, Susani L, Menale C, Muggeo S, Caldana E, Strina D, et al. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells. Stem Cells. 2019;37:876-887 pubmed 出版商

Glennon E, Austin L, Arang N, Kain H, Mast F, Vijayan K, et al. Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection. Cell Rep. 2019;26:3391-3399.e4 pubmed 出版商

Kodama Y, Harinath D, Mihara Tomiyama N, Tominaga N, Ide Y, Nakahara T, et al. Hmga2 regulation of tooth formation and association with Sox2 and Nanog expression. Biochem Biophys Res Commun. 2019;509:1008-1014 pubmed 出版商

Ahmed M, El Sayed A, Chen H, Zhao R, Jin K, Zuo Q, et al. Direct conversion of mouse embryonic fibroblast to osteoblast cells using hLMP-3 with Yamanaka factors. Int J Biochem Cell Biol. 2019;106:84-95 pubmed 出版商

Liu C, Cai Z, Jin G, Peng D, Pan B, Zhang X, et al. Abnormal gametogenesis induced by p53 deficiency promotes tumor progression and drug resistance. Cell Discov. 2018;4:54 pubmed 出版商

Veerapandian V, Ackermann J, Srivastava Y, Malik V, Weng M, Yang X, et al. Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing. Stem Cell Reports. 2018;11:593-606 pubmed 出版商

Lee J, Kim M, Park S, Jang Y. Tousled-like kinase 1 is a negative regulator of core transcription factors in murine embryonic stem cells. Sci Rep. 2018;8:334 pubmed 出版商

Zhang N, Lyu Y, Pan X, Xu L, Xuan A, He X, et al. miR‑146b‑5p promotes the neural conversion of pluripotent stem cells by targeting Smad4. Int J Mol Med. 2017;40:814-824 pubmed 出版商

Ocampo A, Reddy P, Martínez Redondo P, Platero Luengo A, Hatanaka F, Hishida T, et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell. 2016;167:1719-1733.e12 pubmed 出版商

Paulis M, Castelli A, Susani L, Lizier M, Lagutina I, Focarelli M, et al. Chromosome transplantation as a novel approach for correcting complex genomic disorders. Oncotarget. 2015;6:35218-30 pubmed 出版商

Neri T, Muggeo S, Paulis M, Caldana M, Crisafulli L, Strina D, et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Reports. 2015;5:558-68 pubmed 出版商

Kim J, Liu Y, Qiu M, Xu Y. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells. Oncogene. 2016;35:1334-40 pubmed 出版商

Palla A, Piazzolla D, Alcazar N, Cañamero M, Graña O, Gómez López G, et al. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep. 2015;5:10205 pubmed 出版商

Kıykac Altınbaş S, Tapisiz O, Cavkaytar S, Sımşek G, Oguztuzun S, Goktolga U. Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?. Eur J Obstet Gynecol Reprod Biol. 2015;184:7-12 pubmed 出版商

Bertacchi M, Pandolfini L, D Onofrio M, Brandi R, Cremisi F. The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells. Dev Neurobiol. 2015;75:66-79 pubmed 出版商

Piazzolla D, Palla A, Pantoja C, Canamero M, de Castro I, Ortega S, et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun. 2014;5:4226 pubmed 出版商

Carelli S, Messaggio F, Canazza A, Hebda D, Caremoli F, Latorre E, et al. Characteristics and Properties of Mesenchymal Stem Cells Derived From Microfragmented Adipose Tissue. Cell Transplant. 2015;24:1233-52 pubmed 出版商